Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and genetic factors. It is the most common cause of hair loss in both genders. It is characterized by follicular miniaturization in a patterned hair loss occurring due to systemic androgen and genetic factors.

1. Androgenetic Alopecia Treatment Market, by Drug Type
(Topical Agents, 5 AR Inhibitors, and Others), by Route
of Administration (Oral and Topical), by Gender (Male
and Female), by Distribution Channel (Hospital
Pharmacies, Retail Pharmacies, and Online Pharmacies),
and by Region (North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa) - Size, Share,
Outlook, and Opportunity Analysis, 2020 - 2027
Androgenetic alopecia (AGA) is a patterned hair loss occurring due to systemic androgen and
genetic factors. It is the most common cause of hair loss in both genders. It is characterized by
follicular miniaturization in a patterned hair loss occurring due to systemic androgen and
genetic factors. The increasing incidence of androgenetic alopecia is expected to boost the
market growth. According to the National Center for Biotechnology Information (NCBI), in
August 2015, global prevalence of severe androgenetic alopecia (AGA) was 15.33% overall and
varied significantly by geographical region. The risk of having severe androgenetic alopecia
(AGA) increased by 1.092 for per year for the 30 and 40 age group.
The global androgenetic alopecia treatment market is estimated to be valued at US$ 1,607.47
million in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-
2027).

2. Product development and ongoing clinical trials are expected to propel growth of the global
androgenetic alopecia treatment market.
Development of drugs for androgenetic alopecia treatment is expecting to boost the market
growth over the forecast period. For instance, Cairo University is conducting clinical trial of
topical Cetirizine for the treatment of androgenetic alopecia in females. The trial is in Phase
II/III evaluating the efficacy and tolerability of topical cetirizine in female patients with
androgenetic alopecia (AGA). This interventional trial started in February 2020 and the study
expected completed in December 2021.
Get PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/4316
However, side effects of androgenetic alopecia treatment are expected to hinder the market
growth. According to the US Pharmacist, a clinically-focused pharmacy publication, published
an article- Treatment Options for Androgenetic Alopecia, in 2018 that medication used in for
the treatment of androgenetic alopecia has many side effects. For example, topical Minoxidil
can cause local erythema and pruritus and Finasteride can cause dizziness, orthostatic
hypotension and others.
Research and development of treatment for androgenetic alopecia in North America is expected
to boost the market growth.
North America is expected to hold dominant position in the global androgenetic alopecia
treatment market owing to research and development of treatments for androgenetic alopecia in
the region. For instance, on June 4, 2020, Follica, Inc., a biotechnology company developing a
regenerative platform designed to treat androgenetic alopecia, and other related conditions,
announced positive feedback from the U.S. Food and Drug Administration (FDA) for its FOL-004
Phase II released in December 2019. The company advanced its lead program, FOL-004 into
Phase III development, following a successful safety and efficacy optimization study for the
treatment of hair loss in male androgenetic alopecia.

3. Global Androgenetic Alopecia Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
Nationwide lockdowns resulting from COVID-19 in various countries across the globe have
impacted the financial status of businesses in all sectors. The private healthcare is one such
sector which has been impacted significantly by the COVID-19 pandemic.
The lockdown in various countries due to the pandemic has placed an economic burden on the
healthcare sector. Moreover, the coronavirus pandemic has hampered the development,
production, and supply of drugs and other healthcare products and affected growth of
healthcare businesses of various companies across the globe.
As a result, the impact of the COVID-19 pandemic is also expected to limit growth of the
global androgenetic alopecia treatment drugs market during the forecast period.
Key Players
Major players operating in the global androgenetic alopecia treatment market are Histogen Inc.,
Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson
and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH,
PureTech, Vitabiotics, Dr. Reddy’s Laboratories, HCell Inc., Follica, Inc. and Ranbaxy
Laboratories Ltd. among others.
Research Methodology
Coherent Market Insights followsa comprehensive research methodology focused on providing
the most precise market analysis. The company leverages a data triangulation model which
helps company to gauge the market dynamics and provide accurate estimates. Key components
of the research methodologies followed for all our market reports include:
• Primary Research (Trade Surveys and Experts Interviews)
• Desk Research
• Proprietor Data Analytics Model
In addition to this, Coherent Market Insights has access to a wide range of the regional and
global reputed paid data bases, which helps the company to figure out the regional and global

4. market trends and dynamics. The company analyses the industry from the 360 Degree
Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular
details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up
approach is followed to arrive at ultimate research findings
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/4316
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com